CORRIGENDUM: Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk

Masato Nakamura; Kazushige Kadota; Koichi Nakao; Yoshihisa Nakagawa; Junya Shite; Hiroyoshi Yokoi; Ken Kozuma; Kengo Tanabe; Takashi Akasaka; Toshiro Shinke; Takafumi Ueno; Atsushi Hirayama; Shiro Uemura; Atsushi Harada; Takeshi Kuroda; Atsushi Takita; Raisuke Iijima; Yoshitaka Murakami; Shigeru Saito

doi:10.1253/circj.CJ-66-0207

Corrigendum

CORRIGENDUM: Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk

Masato Nakamura, Kazushige Kadota, Koichi Nakao, Yoshihisa Nakagawa, Junya Shite, Hiroyoshi Yokoi, Ken Kozuma, Kengo Tanabe, Takashi Akasaka, Toshiro Shinke, Takafumi Ueno, Atsushi Hirayama, Shiro Uemura, Atsushi Harada, Takeshi Kuroda, Atsushi Takita, Raisuke Iijima, Yoshitaka Murakami, Shigeru Saito

Author information

Masato Nakamura
Kazushige Kadota
Koichi Nakao
Yoshihisa Nakagawa
Junya Shite
Hiroyoshi Yokoi
Ken Kozuma
Kengo Tanabe
Takashi Akasaka
Toshiro Shinke
Takafumi Ueno
Atsushi Hirayama
Shiro Uemura
Atsushi Harada
Takeshi Kuroda
Atsushi Takita
Raisuke Iijima
Yoshitaka Murakami
Shigeru Saito

JOURNAL OPEN ACCESS FULL-TEXT HTML

2022 Volume 86 Issue 6 Pages 1060-

DOI https://doi.org/10.1253/circj.CJ-66-0207

Article (85-6 pp. 785-793)

Details

The authors apologize for the written mistakes in the Discussion section and Supplementary Table 4. Corrections are shown below.

1. Page 791, right column, Lines 13–14

Incorrect:

Also, at 1 month after PCI, 21.5% and 11.4% in the PENDULUM mono…

Correct:

Also, at 1 month after PCI, 21.6% and 11.5% in the PENDULUM mono…

2. Supplementary Table 4

Incorrect:

Correct:

Corresponding author

Register with J-STAGE for free!